Avoid the stress of overpaying for a stock or missing an opportunity by using the right tools and insights to evaluate PMV Pharmaceuticals, Inc. before investing.

In this article, we go over a few key elements for understanding PMV Pharmaceuticals, Inc.’s stock price such as:

• PMV Pharmaceuticals, Inc.’s current stock price and volume
• Why PMV Pharmaceuticals, Inc.’s stock price changed recently
• Upgrades and downgrades for PMVP from analysts
• PMVP’s stock price momentum as measured by its relative strength

About PMV Pharmaceuticals, Inc. (PMVP)

Before we jump into PMV Pharmaceuticals, Inc.’s stock price, history, target price and what caused it to recently dip, let’s take a look at some background.

PMV Pharmaceuticals, Inc., a precision oncology company, engages in the discovery and development of small molecule and tumor-agnostic therapies for p53 mutations in cancer. It’s lead product candidate is rezatapopt, an orally available small molecule that potently and selectively correct p53 misfolding caused by p53 mutation, Y220C, while sparing wild-type p53. The company was formerly known as PJ Pharmaceuticals, Inc. and changed its name to PMV Pharmaceuticals, Inc. in July 2013. PMV Pharmaceuticals, Inc. was incorporated in 2013 and is based in Princeton, New Jersey.

Want to learn more about PMV Pharmaceuticals, Inc.’s stock? Click the button below to subscribe to A+ Investor and get access to everything you need to know about PMV Pharmaceuticals, Inc..

PMV Pharmaceuticals, Inc.’s Stock Price as of Market Close

As of March 09, 2026, 4:00 PM, CST, PMV Pharmaceuticals, Inc.’s stock price was $1.630.

PMV Pharmaceuticals, Inc. is down 0.61% from its previous closing price of $1.640.

During the last market session, PMV Pharmaceuticals, Inc.’s stock traded between $1.550 and $1.690. Currently, there are approximately 53.20 million shares outstanding for PMV Pharmaceuticals, Inc..

PMV Pharmaceuticals, Inc.’s trailing earnings per share are negative, so the stock does not have a meaningful P/E ratio. We suggest investors evaluate other financial metrics to understand its overall valuation.

PMV Pharmaceuticals, Inc. Stock Price History

PMV Pharmaceuticals, Inc.’s (PMVP) price is currently down 4.12% so far this month.

During the month of March, PMV Pharmaceuticals, Inc.’s stock price has reached a high of $1.880 and a low of $1.480.

Over the last year, PMV Pharmaceuticals, Inc. has hit prices as high as $1.880 and as low as $0.810. Year to date, PMV Pharmaceuticals, Inc.’s stock is up 30.4%.

Sign Up to Receive a Free Special Report Showing How A+ Grades Can Help You Make Smarter Investment Decisions

What Caused PMV Pharmaceuticals, Inc. Stock’s Price to Dip?

Stock prices are primarily based on seller supply and buyer demand. But have you ever wondered about what other factors affect a stock's price?

When an analyst changes their opinion of a stock by upgrading or downgrading their rating, it often leads to a sudden stock price adjustment. As of March 09, 2026, there were 0 analysts who downgraded PMV Pharmaceuticals, Inc.’s stock and 1 analyst who upgraded over the last month.

Additionally, you'll want to evaluate PMV Pharmaceuticals, Inc.’s financial health and valuation. Investors can use AAII's Value Grade, which combines six key valuation metrics like P/E and P/S ratios for a comprehensive analysis to conduct analysis on PMV Pharmaceuticals, Inc.’s valuation and financial health. This approach mitigates the limitations of single-metric evaluations.

PMV Pharmaceuticals, Inc.’s current valuation based on AAII’s Value Grade is a A, which means it is considered to be Deep Value.

Learn how to evaluate stocks with AAII Grades and Scores with A+ Investor today.

Lastly, news and media coverage as well as recent press reports about the company or its industry may cause stock prices to fluctuate. You can check out the most recent news articles about PMV Pharmaceuticals, Inc. (PMVP) by visiting AAII Stock Evaluator.

Relative Price Strength of PMV Pharmaceuticals, Inc.

Relative price strength measures a stock's performance against the market, helping investors identify stocks that are outperforming benchmarks.

For AAII’s Momentum Grade, a weighted relative price strength is calculated. Follow this link to learn more about the Momentum Grade.

As of March 09, 2026, PMV Pharmaceuticals, Inc. has a weighted four-quarter relative price strength of 13.31%, which translates to a Momentum Score of 83 and is considered to be Very Strong.

Want to learn more about how PMV Pharmaceuticals, Inc. is graded based on AAII’s composite scores for value, growth, quality and earnings estimate revisions? Subscribe to A+ Investor today.

PMV Pharmaceuticals, Inc. Stock Price: Bottom Line

As of March 9, 2026, PMV Pharmaceuticals, Inc.’s stock price is $1.630, which is down 0.61% from its previous closing price.

AAII advises against making stock decisions based solely on price or past returns. Instead, consider a variety of metrics, fundamentals, and analytics to evaluate a stock like PMV Pharmaceuticals, Inc. stock prices are influenced by market supply and demand and offer just a snapshot of a company's overall health.

Subscribing to AAII's A+ Investor provides access to comprehensive analytics and insights for confident investing.